1The urgency of constructing a method for evaluating the clinical efficacy of traditional Chinese medicine and a three-integrated review system:thoughts on the clinical study of Zhongfeng Xingnao oral prescription for the treatment of acute cerebral hemorrhage published in LancetXU Jia-xin, WANG Jian-xin, YU Zong-liang, GAO Rui785-7892Comparison of innovative drug approvals in China and the United States in 2023GAN Chang-jiao, YUAN Yan-fang, ZHENG Yang, YANG Yue, FANG Jun790-7963Research on the history and effect of incentive policy for pediatric drug development in ChinaHUANG Jian, YANG Yong, LU Xin, XIAN Xue-guo, YAO Zheng-rong797-8034Capivasertib:an inhibitor of the protein kinase B pathwayWANG Xuan, LUO Ying, LIU Xiang-kui804-8105Comparison of application procedures and expedited programs of advanced therapy medical products in China and the United StatesYIN Hui-fang, LI Xiao-fen, QIN Xiao-yan, SU Yi-gang, FAN Jie, FAN Yi811-8226Review on analytical methods for host cell proteins of antibody drugs based on MSXU Xuan, SHENG Ning, ZHANG Jin-lan823-8287Research progress in organoantimony-bismuth complexes in antitumor therapyXIE Wu-xing, LIU Yong-ping, LEI Jian, CHEN Yi829-8368Applications of benchtop NMR in drug analysisPU Heng-ting, LI Jie, ZHANG Na, YU Li-ju, LIU Yang837-8429Quality evaluation and bioequivalence study of posaconazole enteric-coated tabletsWANG Hua-wei, SUI Xin, WU Xiu-jun, CAO Ying, CHEN Lu, LI Xiao-bin, LI Mei-ye, GE Yu-xin, WANG Wen-ping843-84910Study on dissolution curves and permeation rates of rivaroxaban reference tablets from different sourcesMA Ling-yun, WANG Lu-nan, MENG Yu-xin, ZHANG Guang-chao, LIU Qian, NIU Jian-zhao, SUN Hui-min850-85611Dissolution test study of salmeterol xinafoate and fluticasone propionate powder for inhalationWANG Ting, ZHOU Ying, SUN Chun-meng, WEI Ning-yi857-86212Preparation of isosorbide dinitrate tablets and in vitro and in vivo evaluationWANG Nan, LI Zheng-zhao, JIA Jun-wei, FENG Zhong863-87013Prediction and evaluation of quality markers of Gentiana scabra Bge.YU Xue-lin, LIU Jia-yi, DU Jun-nan, WANG Dan, HOU Jian-ming, JIANG Bo-qian, CUI Ji-dan, YIN Hai-bo871-88014Comparison of stability of infusion of different cefuroxime injection preparationsREN Xiao-kai, LI Xiao, ZHANG Lei, AN Jing, LI Ying, ZHAO Yue, FENG Yun-jia, DONG Zhan-jun881-89015Signal mining study of third-generation EGFR-TKI olmutinib based on adverse reaction signals from FAERS databaseWANG Zi-hao, YAN Sen891-896 